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Abstract
This study aimed to compare fat oxidation, hormonal and plasma metabolite kinetics during exercise in lean (L) and obese
(O) men. Sixteen L and 16 O men [Body Mass Index (BMI): 22.960.3 and 39.061.4 kg.m22] performed a submaximal
incremental test (Incr) on a cycle-ergometer. Fat oxidation rates (FORs) were determined using indirect calorimetry. A
sinusoidal model, including 3 independent variables (dilatation, symmetry, translation), was used to describe fat oxidation
kinetics and determine the intensity (Fatmax) eliciting maximal fat oxidation. Blood samples were drawn for the hormonal
and plasma metabolite determination at each step of Incr. FORs (mg.FFM21.min21) were significantly higher from 20 to 30%
of peak oxygen uptake ( _VO2peak) in O than in L and from 65 to 85% _VO2peak in L than in O (p#0.05). FORs were similar in O
and in L from 35 to 60% _VO2peak . Fatmax was 17% significantly lower in O than in L (p,0.01). Fat oxidation kinetics were
characterized by similar translation, significantly lower dilatation and left-shift symmetry in O compared with L (p,0.05).
During whole exercise, a blunted lipolysis was found in O [lower glycerol/fat mass (FM) in O than in L (p#0.001)], likely
associated with higher insulin concentrations in O than in L (p,0.01). Non-esterified fatty acids (NEFA) were significantly
higher in O compared with L (p,0.05). Despite the blunted lipolysis, O presented higher NEFA availability, likely due to
larger amounts of FM. Therefore, a lower Fatmax, a left-shifted and less dilated curve and a lower reliance on fat oxidation at
high exercise intensities suggest that the difference in the fat oxidation kinetics is likely linked to impaired muscular
capacity to oxidize NEFA in O. These results may have important implications for the appropriate exercise intensity
prescription in training programs designed to optimize fat oxidation in O.
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Introduction
Obesity is associated with a variety of health-related risks, such
as hypertension and type 2 diabetes, all of which may center
around insulin resistance [1]. Moreover, insulin resistance seems to
be linked with an impaired ability to oxidize lipids in the skeletal
muscle in obesity [2]. Endurance exercise training at intensity
(Fatmax) eliciting maximal fat oxidation (MFO) may enhance fat
oxidation, muscle oxidative capacity [3] and insulin sensitivity [4]
in obese individuals, suggesting its pivotal role in weight
management in this population.
There is equivocal evidence concerning the effect of obesity on
the fat oxidation rates (FORs) during exercise [5–10]. MFO and
Fatmax were found to be lower in obese compared with lean
individuals [5]. However, recently, Ara et al. [10] suggest that
MFO and Fatmax were higher in class I obese individuals than in
lean controls when groups were matched for aerobic fitness
[similar maximal oxygen uptake ( _VO2max)]. In contrast, when
these groups were not matched for aerobic fitness, no difference
were found in MFO, Fatmax or FORs during low and moderate
exercise intensities (,35–70% _VO2max [11]) [7]. To date, little is
known about MFO, Fatmax and FORs over a large range of
exercise intensities and especially during high intensity exercise
(.64% _VO2max [11]) in obese individuals with a high body mass
index (BMI). In fact, it is realistic to think that such individuals
may not be matched with regard to aerobic fitness with lean
control counterparts. Consequently, it is supposed that FORs over
a large range of exercise intensities and Fatmax may be at least
similar to or lower in obese individuals with a high BMI than in
lean individuals. Moreover, previous studies [7,10] principally
focused on the muscular factor with less emphasis on the extra-
muscular factors (hormones and plasma metabolites) that regulate
fat metabolism during exercise. In fact, the latter may be altered
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by differences in substrate availabilities and lipolytic hormones
between lean and obese individuals, especially at high exercise
intensities [12–15]. This may induce a narrowing of the whole-
body fat oxidation kinetics and a lower Fatmax zone (i.e., the range
of exercise intensities with fat oxidation rates within 10% of MFO
[16]). For a clinical standpoint, this implies that the ‘individual-
ization concept of training’ must be taken into account for weight
management training programs, especially in metabolic disease
[17].
This study aimed to quantitatively characterize and compare
whole-body fat oxidation, hormonal and plasma metabolite
kinetics over a large range of intensities during a submaximal
incremental test in obese with high BMI and lean adults. It was
hypothesized that differences in non-esterified fatty acid (NEFA)
availability and hormonal milieu between the two groups may
decrease FORs at high exercise intensities, inducing a narrowing
of the whole-body fat oxidation kinetics in obese compared with
lean individuals. However, Fatmax, MFO and FORs at low and
moderate intensities may be similar between groups.
Methods and Procedures
Subjects
Sixteen young sedentary lean (L) and 16 young obese (class I:
n = 4, class II: n = 7, and class III: n = 5) men (O) were recruited to
participate in this study (Table 1). O were patients recruited from
the Istituto Auxologico Italiano (Piancavallo, Italy) where they spent 4
weeks. During the first week subjects had physical examination
and clinical routine analysis. Thereafter, they followed a 3-week
personalized lifestyle education program including dietary [a
balanced diet individually prescribed by the nutritionist of the
institute (5761% CHO, 2560% fat, 1861% protein,
2045649 Kcal.d21)], recreational activities at self-controlled
intensity and psychological follow-up. The testing session were
conducted at the end the hospitalization program (,29 days) when
the weight fluctuations were minimal (see methodological discus-
sion). L individuals were recruited and followed a 4-day balanced
diet [with the same macronutrient proportion and with an energy
intake corresponding to ,2000 Kcal.d21] preceding the testing
session. Before the beginning of the testing session, all the subjects
have confirmed that they followed the nutritional indications.
Subjects with hypertension [blood pressure .130/90 mmHg],
impaired fasting glucose (.6.1 mmol.L21) [18], type 2 diabetes
and abnormal electrocardiogram at rest were excluded. None of
the subjects were using any medication known to influence energy
metabolism. Insulin sensitivity was assessed by homeostasis
assessment of insulin resistance (HOMA-IR) [19]. The study was
approved by the Ethics Review Committee of the Istituto Auxologico
Italiano, Italy. All subjects provided written, voluntary, informed
consent before participation. The experiment was conducted
according to the Declaration of Helsinki.
Preliminary testing
All subjects underwent dual-energy X-ray absorptiometry
(DEXA) for measurements of body composition (DPX-IQ X-ray
bone densitometer version 4.7e, USA). For O whose body weight
exceeded 125 kg (n= 6), body composition was assessed using a
tetrapolar bioelectrical impedance method (BIA 101/S, Italy) [20],
and the hydration of each subject was controlled with bioimpe-
dance vector analysis [21]. As BIA tended to overestimate the fat
free mass (FFM) in O [22], for these 6 subjects, we applied a linear
regression between DEXA and BIA of a sample of 20 overweight/
obese hospitalized men patients (BMI range: 25 – 52 kg.m22) to
transform the FFM BIA’s data. Repeated regressions removing
one subject at a time allowed us to assess the accuracy of the linear
regression. Peak oxygen uptake ( _VO2peak) and peak power output
(PPO) were determined by a maximal ramp incremental test to
exhaustion on a cycle-ergometer (Ebike Basic BPlus, USA). After a
3-min rest period, O started with a 5-min warm-up at 40 W (60 W
for L), after which the PO was linearly increased by 20 W (30 W
for L) every minute until exhaustion. _VO2, carbon dioxide
production ( _VCO2) and ventilation ( _VE ) were measured contin-
uously using a breath-by-breath online system (Vmax 229, Sensor
Medics, USA). Heart rate (HR) was recorded continuously using
an HR monitor (Polar RS800, Finland). _VO2peak was defined as
the highest 10-s mean value recorded before the subject’s
volitional termination of the test, whereas PPO was defined as
the highest peak value reached during the maximal incremental
ramp test.
Experimental protocol
Seven days after the preliminary test, the experimental trial was
performed in the morning (between 0800-0900 hours) after a
minimum 12-h overnight fast. All participants were asked to
refrain from exercise, alcohol, and caffeine for the 24-h period
preceding the test. After a 15-min seated resting period, the
subjects remained seated for 15 min on the cycle-ergometer and
were connected to the metabolic system (Rest). Average HR and
gas exchange data during the final 2 min were used as the baseline.
Thereafter, subjects performed a submaximal incremental test
(Incr) to determine the whole-body fat oxidation kinetics. After a
standardized 10-min warm-up at 20% PPO, the PO was increased
by 7.5% PPO every 6 min until 65% PPO or until the respiratory
exchange ratio (RER) reached 1.0. HR and respiratory values
were averaged over the last minute of each stage.
The blood samples were drawn at Rest and during the last 3
min of the warm-up and each step to determine serum insulin and
NEFA, plasma epinephrine (E), norepinephrine (NE), glycerol,
atrial natriuretic peptide (ANP), glucose and lactate concentra-
tions. The blood samples were collected through an indwelling
cannula inserted at the antecubital vein, which was kept patent by
continuous slow saline infusion. All blood aliquots were placed on
ice, and after the final step were centrifuged at 4uC and 3,000 G
for 10 min. Plasma or serum samples were transferred to storage
tubes and frozen at –80uC until analysis.
Table 1. Characteristics of the study subjects.
Lean Obese P value
N 16 16 -
Age, yr 33.161.6 34.562.1 NS
Weight, kg 72.461.2 121.364.8 # 0.001
Height, m 1.7860.01 1.7660.02 NS
BMI, kg.m22 22.960.3 39.061.4 # 0.001
Fat mass, kg 13.761.0 51.863.8 # 0.001
Fat mass, % 19.861.3 42.461.4 # 0.001
Fat free mass, kg 55.761.3 68.161.7 # 0.001
Fasting glucose, mmol.L21 5.260.1 5.360.1 NS
Fasting insulin, mU.L21 4.560.9 15.964.1 , 0.01
HOMA-IR 1.060.2 3.861.0 # 0.001
Values are the means6SE. BMI: body mass index; HOMA-IR: homeostasis
assessment of insulin resistance; NS: non significant.
doi:10.1371/journal.pone.0088707.t001
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Data analysis and calculations
Indirect calorimetry. Fat and CHO oxidation rates were calculated
using stoichiometric equations [23]. The results of the Incr were
used to calculate FORs over a wide range of exercise intensities.
To model whole-body fat oxidation kinetics, represented as a
function of exercise intensity, and determine Fatmax and MFO, the
SIN model was used [24]. The SIN model includes 3 independent
variables, representing the main quantitative characteristics of the
curve: dilatation, symmetry, and translation (Equation 1).
%MFO~sin p
1
pz2d
K :% _VO2peakzdzt
  s 
[1]
where d, s, and t are the dilatation, symmetry, and translation
variables, respectively, and K is the constant of intensity, which
corresponds to (p /100). Dilatation refers to the degree of
dilatation or retraction of the curve; the symmetry variable is used
to break the symmetry of the standard basic sine curve, and
translation refers to the translation of the whole curve toward the
abscissa axis [24]. The FORs were determined at intervals of 5%
_VO2peak between 20–85% _VO2peak. The Fatmax zone was
determined by calculating the range of exercise intensities with
fat oxidation rates within 10% MFO [16]. In addition, %HRmax
and RER (RERFatmax) at Fatmax were determined. Delta efficiency
(DE) was calculated as previously described [25].
Blood samples. Serum insulin concentrations were measured by
chemiluminescence (Immulite 2000 Analyzer, USA). The insulin
assay sensitivity was 2 mlU.mL21; the inter- and intra-assay
coefficients of variation (CVs) were 4.0 and 5.1%, respectively.
Serum NEFA concentrations were analyzed spectrophotometri-
cally using commercial enzymatic and colorimetric kits (Randox
Laboratories, USA). The NEFA assay sensitivity was
0.072 mmol.L21; the inter- and intra-assay CVs were 4.51 and
4.74%, respectively. The E and NE plasma concentrations were
determined with high-performance liquid chromatography
(HPLC) using kits from Chromosystems (Chromsystems Instru-
ments & Chemicals GmbH, Germany). The sensitivities of these
assays and the inter- and intra-assay CVs were as follows:
10 ng.L21, 4.0 and 2.9% for E, and 15 ng.L21, 1.7 and 3.7% for
NE, respectively. Plasma glycerol concentrations were measured
using an enzymatic and colorimetric commercial assay kit
(Cayman Chemical Company, USA); the inter- and intra-assay
CVs were 6.5 and 6.5%, respectively. Samples for plasma ANP
were preconditioned with aprotinin (500 Kallikrein inhibition
units per mL), and plasma ANP concentrations were determined
using a EURIA kit with prior extraction (EURO-Diagnostic,
Sweden; sensitivity 3.5 pg.mL21); inter- and intra-assay CVs were
11.6% and 8.6%, respectively. Plasma glucose and lactate
concentrations were assessed using an amperometric method
(Gem Premier 3000; Instrumentation Laboratory, USA).
Statistical analysis
A 2-way repeated-measures mixed design ANOVA followed by
contrasts was performed to compare RER and fat oxidation at
absolute PO [exercise intensity (n = 9; 30–150W) x group (obese vs.
lean)] and RER, HR, _VE , and fat oxidation at each relative
exercise intensity (% _VO2peak) [exercise intensity (n = 14; 20–85%
_VO2peak) x group (obese vs. lean)]. This test was also used to
compare plasma metabolite and hormonal kinetics at rest and at
each relative exercise intensity (% PPO) [exercise intensity (n = 7;
Rest-57.5% PPO) x group (obese vs. lean)] during Incr between L
and O. A t test (or Mann–Whitney rank sum test for
nonparametric values) was used to identify differences in the
parameters (Fatmax, Fatmax zone and MFO) and in the SIN model
variables (dilatation, symmetry and translation) of the whole-body
fat oxidation kinetics obtained during Incr. These tests were also
used to determine differences in anthropometric and physical
characteristics between O and L. Significance was set at p#0.05.
Results
Anthropometric characteristics and maximal incremental
ramp test
There was no significant difference in age and height between
the two groups (Table 1). Weight, BMI, fat mass (FM) and FFM
were significantly higher in O compared with L (Table 1). Fasting
glucose was similar in O and L, whereas fasting insulin and
HOMA-IR were significantly higher in O compared with L (Table
1). _VO2peak (mL
.min21.kg21 and mL.FFM21.min21), PPO, and
HRmax were significantly lower in O than in L, whereas _VO2peak
(mL.min21) was similar in the two groups (Table 2).
Pre-exercise resting period
_VO2 (6.160.3 and 6.360.3 mL
.FFM21.min21), HR (7362
and 7463 beats.min21), _VE (10.760.4 and 11.060.7 L
.min21)
and FORs (2.560.3 and 1.960.2 mg.FFM21.min21) were similar
in O and in L, respectively. RER was significantly lower in O than
in L (0.7660.01 and 0.8360.02, respectively; p#0.01).
Submaximal incremental test
RER showed a significant interaction effect (p#0.01) and was
significantly lower from 30 to 60 W in O than in L (Figure 1A,
p,0.05) and from 20 to 55% _VO2peak in O than in L (Figure 1B,
p,0.05). FORs, expressed in g.min21, showed a significant
interaction effect (p#0.001) and were significantly higher from
30 to 75 W in O than in L (p#0.01) and at 150 W in L than in O
Table 2. Maximal incremental ramp test and characteristics
of whole-body fat oxidation kinetics during the submaximal
incremental test (Incr).
Lean Obese P value
Maximal incremental ramp test
_VO2peak , mL
.min21 30036138 30526106 NS
_VO2peak , mL
.min21.kg21 41.861.8 25.260.9 # 0.001
_VO2peak , mL
.FFM21.min21 53.861.7 44.961.3 # 0.001
PPO, W 259613 21367 , 0.01
HRmax, bpm 18362 16862 # 0.001
Submaximal incremental test
MFO, mg.FFM21.min21 6.360.4 6.160.3 NS
Fatmax, % _VO2peak 56.861.7 47.262.6 , 0.01
Fatmaxzone, % _VO2peak 29.461.0 25.161.3 , 0.05
Fatmax, % HRmax 73.861.7 65.262.3 , 0.01
RERFatmax 0.8860.00 0.8360.01 # 0.001
Dilatation 0.260.1 –0.160.1 # 0.001
Symmetry 1.260.1 1.060.0 , 0.05
Translation 0.060.1 0.160.1 NS
Values are the means6SE. _VO2peak : peak oxygen uptake; FFM: fat-free mass;
PPO: peak power output; HRmax: maximal heart rate; Fatmax: exercise intensity at
which maximal fat oxidation rate (MFO) occurs; Fatmax zone: range of exercise
intensities with fat oxidation rates within 10% MFO; RER: respiratory exchange
ratio; NS: non significant.
doi:10.1371/journal.pone.0088707.t002
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(Figure 2A, p,0.05). FORs, expressed in g.min21, showed a
significant interaction effect (p#0.001) and were significantly
higher from 20 to 45% _VO2peak in O than in L (p#0.01) and at
85% _VO2peak in L than in O (Figure 2B, p,0.05). FORs,
expressed in mg.FFM21.min21, showed a significant interaction
effect (p#0.001) and were significantly higher from 20 to 30%
_VO2peak in O than in L (p#0.05) and from 65 to 85% _VO2peak in
L than in O (Figure 2C, p#0.05). Whole-body fat oxidation
kinetics were characterized by similar translation, significantly
lower dilatation and left-shift symmetry in O compared with L
(Table 2, Figure 2D). MFO was similar in O and in L, and Fatmax,
Fatmax zone and RERFatmax were significantly lower in O
compared with L (Table 2). HR showed a significant interaction
effect (p#0.001) and was significantly lower from 35 to 85%
_VO2peak in O than in L (data not shown, p,0.05). DE was similar
in O and L (18.660.5 and 19.860.7%, respectively). _VE and
_VCO2 respiratory equivalent showed no significant main group
effect and no significant interaction effect (data not shown).
Figure 1. Mean respiratory exchange ratio (RER) values represented as a function of exercise intensity [absolute power output (A)
and % of peak oxygen uptake ( _VO2peak) (B)] determinedduring thesubmaximal incremental test in lean (L:blue,n =16) andobese (O:
=16) individuals. Values are the means6SE. * p#0.05 for differences with lean; { p#0.05 for significant group interaction effect.
doi:10.1371/journal.pone.0088707.g001
Obesity and Fat Oxidation
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Plasma metabolite and hormonal concentrations
There were no significant main group and interaction effects for
plasma glucose and lactate concentrations (data not shown).
Plasma NEFA concentrations showed a significant main group
effect (p,0.01) with no significant interaction effect and were
significantly higher at Rest and for all exercise intensities in O than
in L (Figure 3A, p,0.05). Plasma glycerol concentrations showed a
significant interaction effect (p#0.001) and were significantly
higher at Rest and for all exercise intensities in O than in L (Figure
3B, p,0.05). Plasma glycerol concentrations divided by kg of FM
were significantly lower at Rest and for all exercise intensities in O
than in L [Figure 3C, p#0.001; significant interaction effect
(p#0.001)].
Plasma E concentrations showed a significant interaction effect
(p,0.01) and were significantly lower at 42.5 and 50% PPO in O
than in L (Figure 4A, p,0.05). There were no significant main
group or interaction effects for plasma NE and ANP concentra-
tions (Figures 4B and 4C, respectively). Plasma insulin concentra-
tions showed a significant main group effect (p,0.01), with no
significant interaction effect, and were significantly higher at Rest
and for all exercise intensities in O than in L (Figure 4D, p,0.01).
Discussion
The results of this study showed that O presented a lower
Fatmax, a left-shifted and less dilated curve and a lower reliance on
fat oxidation at high but not at low or moderate exercise
intensities. Moreover, MFO was similar in the two groups.
Lipolysis (attested by glycerol/FM concentrations) was found to be
lower in O during all exercise intensities, and blunted lipolysis was
most likely associated with lower E concentrations (significant
interaction effect between the two groups) and/or hyperinsulin-
emia. Despite the blunted lipolysis, O presented higher NEFA
availability, most likely due to larger amounts of FM. Therefore,
contrary to our hypothesis, these results suggest that the decreased
FORs in O relative to L at high exercise intensities are not
associated with decreased plasma NEFA availability, but most
likely linked to impaired muscular capacity to oxidize NEFA.
The absolute _VO2peakvalues were similar between O and L
counterparts and are in line with previous studies that tested, on
cycle-ergometer, individuals with similar class of obesity
[6,8,26,27]. However, as our O presented lower HRmax values
compared to L individuals during the maximal ramp incremental
test, _VO2peak may be likely underestimated in O individuals and
representing variables as a function of % _VO2peak would interfere
with the comparison of the two groups. For this reason, before to
represent our results according to the % _VO2peak, RER and FORs
have been expressed and analyzed as a function of absolute PO,
which was actually measured during Incr. However, this analysis
gives similar results compared with that expressing these variables
as a function of % _VO2peak (Figures 1 and 2). Moreover, it has been
suggested that _VO2peak may also be indicative of a true maximal
oxygen consumption ( _VO2max) in lean [28] and in obese
individuals [29] and previous studies compared FORs in obese
and lean individuals reporting FORs as a function of _VO2max
[7,10]. Therefore, representing variables as a function of
% _VO2peak may be a reasonable choice for both groups and may
add important information of difference in FORs in L and O
Figure 2. Mean whole-body fat oxidation kinetics in absolute [g.min21 (A and B) and mg.FFM21.min21 (C)] and relative [% of
maximal fat oxidation (MFO) (D)] values determined with the sinusoidal (SIN) model and during the submaximal incremental test
in lean (L: blue, n=16) and obese (O: red, n=16) individuals. Values are the means6SE. _VO2peak : peak oxygen uptake. * p#0.05 for
differences with lean; { p#0.05 for significant group interaction effect.
doi:10.1371/journal.pone.0088707.g002
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Figure 3. Mean non-esterified fatty acid (NEFA) concentrations (A) and mean glycerol concentrations (B) divided by fat mass (C)
during the submaximal incremental test in lean (L: blue, n=16) and obese (O: red, n=14) individuals. Values are the means6SE. PPO:
peak power output. * p#0.05 for differences with lean; { p#0.05 for significant group interaction effect.
doi:10.1371/journal.pone.0088707.g003
Obesity and Fat Oxidation
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individuals. Moreover, this allows us to compare our results to
previous findings [7,10].
Our results, according to previous findings [6,30], showed that
RER was lower in obese compared to lean counterparts,
indicating a greater proportion of energy derived from fat during
low-to-moderate exercise intensities. Indeed, the fat oxidation
kinetics, expressed in g.min21, present higher values in O than in
L during low intensities (i.e., 20–45% _VO2peak, Figure 2B),
confirming those of Ara et al. [10], who showed higher rates of fat
oxidation between groups matched for aerobic fitness and with
similar FFM. Contrary to Ara et al. [10], our results showed that
obese individuals presented lower FORs during high exercise
intensities inducing therefore a significant interaction effect
between the two groups. However, as our O presented higher
FFM values, these observations report only indications of the
global fat oxidation irrespective of differences in FFM between the
two groups. Therefore, expressing the FORs in mg.FFM21.min21
seems to be more judicious with regard to obtaining information
about fat oxidation at the skeletal muscle level. Our results showed
that the FORs per kg of FFM were higher in O than in L during
low exercise intensities (20–30% _VO2peak), similar during moder-
ate exercise intensities (50–60% _VO2peak) and higher in L than in
O during high exercise intensities (65–85% _VO2peak; Figure 2C).
Moreover, the significant interaction effect clearly demonstrates
that the pattern of fat oxidation kinetics was different in the two
groups, substantially confirming the findings of FORs expressed in
g.min21. In addition, as the FORs may be affected by the aerobic
fitness [31], the SIN model, using relative FORs values (%MFO,
Figure 2D), allows us to compare the fat oxidation kinetics
independently of differences in aerobic fitness between the two
groups. This comparison showed that obese individuals presented
a left-shifted and less dilated curve compared to lean individuals,
associated with a lower reliance on fat oxidation at high exercise
intensities. The different profiles observed according to exercise
intensity may be mainly attributable to differences between the
two groups in 1) the modulation of lipolysis in adipose tissue (AT)
and NEFA availability for skeletal muscle and/or 2) the lipid
oxidation in skeletal muscle during exercise.
Our findings showed that glycerol/FM concentrations were
lower in O than in L for all exercise intensities with a significant
interaction effect between groups, suggesting blunted lipolysis in
O. This finding may be explained by the lower E concentrations at
moderate intensities in O than in L and by the significant
interaction effect for E between L and O (Figure 4A). In fact, it has
been recently shown that E, and not NE, is a determinant of
exercise-induced lipid mobilization in human subcutaneous AT
[32]. Moreover, as E concentrations were not significantly
different at rest and during low exercise intensities between the
two groups, higher insulin concentrations may also contribute to
the blunted lipolysis in O [8]. In addition, although previous
studies suggested that the plasma ANP (a stimulator of lipolysis in
AT [33]) is lower in obese than in lean individuals [34] (most likely
linked to a higher expression of natriuretic peptide clearance
receptors in AT with obesity [35]), our results showed no
difference between O and L at Rest and during exercise. Indeed,
it has been suggested that ANP receptor expression in AT was
reduced in obese hypertensive but not in non-hypertensive obese
individuals [35], suggesting that the alteration of ANP-induced
cardio-metabolic actions may be related to hypertension [36].
However, because our O were not hypertensive, it is difficult to
relate the blunted lipolysis in O with lower ANP receptor
expression in AT.
Interestingly, higher absolute concentrations of NEFA and
glycerol were found during all exercise intensities in O, suggesting
that higher NEFA availability may be due to larger amounts of
FM in these individuals [37]. Moreover, the NEFA concentration
profiles display similar kinetics in both groups, indicating that
Figure 4. Mean epinephrine (A), norepinephrine (B), atrial natriuretic peptide (C) and insulin (D) concentrations during the
submaximal incremental test in lean (L: blue, n=16) and obese (O: red, n=14) individuals. Values are the means6SE. PPO: peak power
output. * p#0.05 for differences with lean; { p#0.05 for significant group interaction effect.
doi:10.1371/journal.pone.0088707.g004
Obesity and Fat Oxidation
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NEFA availability cannot explain the different patterns of fat
oxidation kinetics with regard to exercise intensities between the 2
groups. Therefore, contrary to our hypothesis, the lower FORs in
O relative to L at high exercise intensities were not due to
decreased plasma NEFA availability. Furthermore, despite a
continuous increase in lipolysis (Figure 3), the stable plasma NEFA
concentrations observed during Incr may suggest an enhanced
NEFA uptake with respect to exercise intensities by skeletal muscle
cells in both groups. Moreover, it has been suggested that
extremely obese individuals (BMI: , 40 kg.m22) present a lower
percentage of NEFA uptake oxidized during exercise compared to
lean individuals [9], suggesting that NEFA that were taken up but
not oxidized were re-esterified in the muscle, leading to enhanced
rates of fat storage [6]. The reduced FORs at high exercise
intensity may be linked to the decreased activity of the muscle
carnitine palmitoyltransferase (CPT-1) and muscle citrate synthase
(CS) (an index of mitochondrial content) in obese subjects relative
to lean controls [1,38,39]. Although we do not know whether O
presented higher NEFA uptake and/or decreased muscle CPT-1
and CS activity than L, we suggest that O may oxidize a lower
percentage of NEFA uptake, leading to decreased FORs as the
exercise intensity increases.
Moreover, as previously reported [8,9], O can maintain total
lipid oxidation at rest and during moderate exercise only if they
can compensate for the reduction in plasma NEFA oxidation with
enhanced intra-muscular triglyceride (IMTG) oxidation. The
higher and similar FORs in O compared with L during low and
moderate exercise intensities, respectively, seem to confirm this
mechanism. Moreover, the latter results are in line with previous
findings showing that similar insulin resistant obese individuals
with normoglycemia used more fat and may have been more
reliant to IMTG during low intensity exercise (,45% _VO2peak)
compared with insulin sensitive obese counterparts [40]. However,
our results may indicate that this IMTG compensation may not be
possible at high exercise intensities, leading to decreased FORs in
O compared with L. In fact, it has been shown that IMTG
oxidation decreases to a greater extent than plasma NEFA
oxidation as the exercise intensity increases from moderate to high
[41]. Thus, plasma NEFA oxidation, which represents a more
important part of the total lipid oxidation during high exercise
intensities, may exert a more substantial limiting effect and thus
decrease the total lipid oxidation at these intensities in O.
Therefore, we suggest that O may have a muscular defect in the
Figure 5. Mean glycerol concentrations (A) divided by fat mass (B), mean non-esterified fatty acid (NEFA) concentrations (C) and
whole-body fat oxidation kinetics in relative (D) [% of maximal fat oxidation (MFO)] values determined with the sinusoidal (SIN)
model during the submaximal incremental test in lean (L: dark and light blue) and obese (O: dark and light red) individuals. In the
sub-groups matched for aerobic fitness, O present similar MFO (O: 6.360.6; L: 5.560.4 mg.FFM21.min21), left-shifted (O: 0.960.1; L: 1.260.1 for
symmetry; p,0.05) and less dilated (O: –0.160.1; L: 0.360.1 for dilatation; p,0.05) curve, lower Fatmax (O: 46.565.0; L: 55.862.6 % _VO2peak) and lower
Fatmax zone (O: 25.862.3; L: 30.161.2 % _VO2peak) although non-significant as a consequence of the small sample size. Values are the means6SE. PPO:
peak power output. * p#0.05 for differences between sub-groups; { p#0.05 for significant group interaction effect between sub-groups; $ for
significant group effect between sub-groups [2-way repeated-measures mixed design ANOVA (exercise intensity x group) followed by contrasts].
doi:10.1371/journal.pone.0088707.g005
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ability to oxidize lipids [38,39] at high exercise intensities, most
likely due to decreased plasma NEFA oxidation [6,9].
Our results are in contrast with those of Ara et al. who found
higher FORs during all exercise intensities and higher Fatmax and
MFO in obese compared with lean individuals. The reason for this
discrepancy is unclear but may be a result of different factors, such
as the degree of adiposity and the BMI (,39 versus,34 kg.m22 for
O and ,23 versus ,27 kg.m22 for L). Furthermore, the O in this
study were not matched with regard to _VO2peak/FFM; therefore,
it is possible that the fat oxidation kinetics, MFO and Fatmax results
were influenced by differences in metabolic fitness and, thus, not
directly associated with obesity. Therefore, we created a sub-group
of 8 O (BMI: 39.162.0 kg.m22) and 8 L (BMI: 23.560.4 kg.m22)
matched for _VO2peak/FFM (O: 48.761.6 mL
.FFM21.min21; L:
48.861.7 mL.FFM21.min21, p=0.94). This new comparison
showed that the sub-group of obese individuals presented, as
observed in the entire group (n = 16), a blunted lipolysis (Figure
5B) and higher NEFA availability (although non-significant as a
consequence of the small sample size, Figure 5C) during all
exercise intensities compared to lean individuals. In addition,
despite this higher NEFA availability, the shape of fat oxidation
kinetics during exercise was similar to that observed in the entire
group (n= 16) and remains significantly left-shifted and less dilated
compared to lean individuals (Figure 5D). This suggests that the
lower reliance to fat oxidation at high exercise intensities may be
directly associated with obesity and not with differences in aerobic
fitness between the 2 groups.
Our results may also be relevant from a clinical standpoint and
for exercise prescription in O. In fact, Fatmax was found to be lower
in O than in L, and its values were similar to those reported in the
literature in lean [5,31] and obese individuals [4,7,10]. The lower
Fatmax and Fatmax zone in O compared to L suggest that the
‘individualization concept of training’ must be taken into account
for weight management training programs. Training programs in
class II and III O are rare, but targeting the training intensity in
the zone that elicits MFO appears to be appropriate [4].
Some methodological limitations exist and need to be
addressed. Firstly, our O were studied during a lifestyle education
program, and therefore this condition may interfere with our
findings and not be completely representative of the general obese
population. However, the testing session was conducted at the end
of the hospitalization program, when the weight changes were
minimal. In addition, contrary to previous studies that performed
only one day of diet control before the trial [5,7,10], our O
followed a 3-week balanced diet before the testing session.
Moreover, although our O may present a favourable condition
to promote fat oxidation [42,43], the decreased FORs observed
during high exercise intensities and the lower dilatation may
suggest that obese individuals really suffer from an impaired
capacity to oxidize lipids. Secondly, although indirect calorimetry
is extensively used to determine substrate oxidation during
exercise, changes in the size of the bicarbonate pool may interfere
with calculations of substrate oxidation at higher intensities [44].
However, it has been shown that close agreement exists between
the estimates of substrate oxidation rates measured with indirect
calorimetry and by an isotope method during strenuous exercise at
,85% of _VO2max [45]. Moreover, our results of _VE and _VCO2
respiratory equivalent, represented as a function of exercise
intensity, showed that there was no difference between groups,
suggesting that indirect calorimetry may be accurately used to
assess and compare substrate oxidation in the two groups.
In summary, this study showed that O with high BMI presented
a left-shifted and less dilated curve and a lower reliance on fat
oxidation at high but not at low or moderate exercise intensities.
Despite the blunted lipolysis, O presented higher NEFA availabil-
ity (most likely due to larger amounts of FM), suggesting that the
decreased FORs in O at high exercise intensities are most likely
linked to impaired muscular capacity to oxidize lipids. In addition,
the different pattern of fat oxidation kinetics between the two
groups may be directly associated with obesity and not with
differences in aerobic fitness. The narrowing of the FORs and the
lower Fatmax and Fatmax zone may have important implications for
the appropriate exercise intensity prescription in training pro-
grams designed to optimize fat oxidation in O.
Acknowledgments
We thank Dr. Paolo Fanari for his helpful assistance in the laboratory,
Ivana Di Sabato for blood analysis and Dr. Francesca Amati for her helpful
suggestions and criticism.
Author Contributions
Conceived and designed the experiments: SL FC MC SM AS AB DM.
Performed the experiments: SL FC MC SM. Analyzed the data: SL SM
AS AB DM. Contributed reagents/materials/analysis tools: SL FC MC
SM AS AB DM. Wrote the paper: SL DM.
References
1. Houmard JA, Pories WJ, Dohm GL (2012) Severe obesity: evidence for a
deranged metabolic program in skeletal muscle? Exerc Sport Sci Rev 40: 204–
210.
2. Houmard JA (2008) Intramuscular lipid oxidation and obesity. Am J Physiol
Regul Integr Comp Physiol 294: R1111–1116.
3. Bordenave S, Metz L, Flavier S, Lambert K, Ghanassia E, et al. (2008) Training-
induced improvement in lipid oxidation in type 2 diabetes mellitus is related to
alterations in muscle mitochondrial activity. Effect of endurance training in type
2 diabetes. Diabetes Metab 34: 162–168.
4. Venables MC, Jeukendrup AE (2008) Endurance training and obesity: effect on
substrate metabolism and insulin sensitivity. Med Sci Sports Exerc 40: 495–502.
5. Perez-Martin A, Dumortier M, Raynaud E, Brun JF, Fedou C, et al. (2001)
Balance of substrate oxidation during submaximal exercise in lean and obese
people. Diabetes Metab 27: 466–474.
6. Goodpaster BH, Wolfe RR, Kelley DE (2002) Effects of obesity on substrate
utilization during exercise. Obes Res 10: 575–584.
7. Larsen S, Ara I, Rabol R, Andersen JL, Boushel R, et al. (2009) Are substrate
use during exercise and mitochondrial respiratory capacity decreased in arm and
leg muscle in type 2 diabetes? Diabetologia 52: 1400–1408.
8. Mittendorfer B, Fields DA, Klein S (2004) Excess body fat in men decreases
plasma fatty acid availability and oxidation during endurance exercise. Am J
Physiol Endocrinol Metab 286: E354–362.
9. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, et al. (2004)
Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol
Endocrinol Metab 287: E1076–1081.
10. Ara I, Larsen S, Stallknecht B, Guerra B, Morales-Alamo D, et al. (2011)
Normal mitochondrial function and increased fat oxidation capacity in leg and
arm muscles in obese humans. Int J Obes (Lond) 35: 99–108.
11. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, et al. (2011)
American College of Sports Medicine position stand. Quantity and quality of
exercise for developing and maintaining cardiorespiratory, musculoskeletal, and
neuromotor fitness in apparently healthy adults: guidance for prescribing
exercise. Med Sci Sports Exerc 43: 1334–1359.
12. Frayn KN (2010) Fat as a fuel: emerging understanding of the adipose tissue-
skeletal muscle axis. Acta Physiol (Oxf) 199: 509–518.
13. De Glisezinski I, Crampes F, Harant I, Berlan M, Hejnova J, et al. (1998)
Endurance training changes in lipolytic responsiveness of obese adipose tissue.
Am J Physiol 275: E951–956.
14. Mauriege P, Despres JP, Prud’homme D, Pouliot MC, Marcotte M, et al. (1991)
Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res
32: 1625–1633.
15. Stich V, De Glisezinski I, Crampes F, Hejnova J, Cottet-Emard JM, et al. (2000)
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in
SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol 279: R499–
504.
Obesity and Fat Oxidation
PLOS ONE | www.plosone.org 9 February 2014 | Volume 9 | Issue 2 | e88707
16. Achten J, Gleeson M, Jeukendrup AE (2002) Determination of the exercise
intensity that elicits maximal fat oxidation. Med Sci Sports Exerc 34: 92–97.
17. Brun JF, Malatesta D, Sartorio A (2012) Maximal lipid oxidation during
exercise: A target for individualizing endurance training in obesity and diabetes?
J Endocrinol Invest 35: 686–691.
18. World Health Organisation (2006) Definition and diagnosis of diabetes mellitus
and intermediate hyperglycemia: report of a WHO/IDF Consultation. 1–50 p.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985)
Homeostasis model assessment: insulin resistance and beta-cell function from
fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–
419.
20. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA (1986) Validation of
tetrapolar bioelectrical impedance method to assess human body composition. J
Appl Physiol 60: 1327–1332.
21. Piccoli A, Brunani A, Savia G, Pillon L, Favaro E, et al. (1998) Discriminating
between body fat and fluid changes in the obese adult using bioimpedance vector
analysis. Int J Obes Relat Metab Disord 22: 97–104.
22. Baumgartner RN, Ross R, Heymsfield SB (1998) Does adipose tissue influence
bioelectric impedance in obese men and women? J Appl Physiol 84: 257–262.
23. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous
exchange. J Appl Physiol 55: 628–634.
24. Cheneviere X, Malatesta D, Peters EM, Borrani F (2009) A mathematical model
to describe fat oxidation kinetics during graded exercise. Med Sci Sports Exerc
41: 1615–1625.
25. Mogensen M, Bagger M, Pedersen PK, Fernstro¨m M, Sahlin K (2006) Cycling
efficiency in humans is related to low UCP3 content and to type I fibres but not
to mitochondrial efficiency. J Physiol 571: 669–681.
26. Stich V, de Glisezinski I, Galitzky J, Hejnova J, Crampes F, et al. (1998)
Endurance training increases the beta-adrenergic lipolytic response in
subcutaneous adipose tissue in obese subjects. Int J Obes Relat Metab Disord
23: 374–381.
27. Wong T, Harber V (2006) Lower excess postexercise oxygen consumption and
altered growth hormone and cortisol responses to exercise in obese men. J Clin
Endocrinol Metab 91: 678–686.
28. Day JR, Rossiter HB, Coats EM, Skasick A, Whipp BJ (2003) The maximally
attainable VO2 during exercise in humans: the peak vs. maximum issue. J Appl
Physiol (1985) 95: 1901–1907.
29. Wood RE, Hills AP, Hunter GR, King NA, Byrne NM (2010) Vo2max in
overweight and obese adults: do they meet the threshold criteria? Med Sci Sports
Exerc 42: 470–477.
30. Kanaley JA, Weatherup-Dentes MM, Alvarado CR, Whitehead G (2001)
Substrate oxidation during acute exercise and with exercise training in lean and
obese women. Eur J Appl Physiol 85: 68–73.
31. Nordby P, Saltin B, Helge JW (2006) Whole-body fat oxidation determined by
graded exercise and indirect calorimetry: a role for muscle oxidative capacity?
Scand J Med Sci Sports 16: 209–214.
32. De Glisezinski I, Larrouy D, Bajzova M, Koppo K, Polak J, et al. (2009)
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid
mobilization in human subcutaneous adipose tissue. J Physiol 587: 3393–3404.
33. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J (2000)
Natriuretic peptides: a new lipolytic pathway in human adipocytes. Faseb J 14:
1345–1351.
34. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, et al. (2004) Impact of
obesity on plasma natriuretic peptide levels. Circulation 109: 594–600.
35. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, et al. (1997)
Plasma atrial natriuretic peptide and natriuretic peptide receptor gene
expression in adipose tissue of normotensive and hypertensive obese patients. J
Hypertens 15: 1695–1699.
36. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, et al. (2001)
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to
sympathetic nervous system activation or obesity in young men. J Lipid Res
42: 536–544.
37. Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin
resistance: time for a reevaluation. Diabetes 60: 2441–2449.
38. Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty
acid metabolism in association with insulin resistance, obesity, and weight loss.
Am J Physiol 277: E1130–1141.
39. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA (2000) Lipid
oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol
Metab 279: E1039–1044.
40. Braun B, Sharoff C, Chipkin SR, Beaudoin F (2004) Effects of insulin resistance
on substrate utilization during exercise in overweight women. J Appl Physiol 97:
991–997.
41. van Loon LJ (2004) Use of intramuscular triacylglycerol as a substrate source
during exercise in humans. J Appl Physiol 97: 1170–1187.
42. Solomon TP, Sistrun SN, Krishnan RK, Del Aguila LF, Marchetti CM, et al.
(2008) Exercise and diet enhance fat oxidation and reduce insulin resistance in
older obese adults. J Appl Physiol 104: 1313–1319.
43. van Aggel-Leijssen DP, Saris WH, Hul GB, van Baak MA (2001) Short-term
effects of weight loss with or without low-intensity exercise training on fat
metabolism in obese men. Am J Clin Nutr 73: 523–531.
44. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review.
Metabolism 37: 287–301.
45. Romijn JA, Coyle EF, Hibbert J, Wolfe RR (1992) Comparison of indirect
calorimetry and a new breath 13C/12C ratio method during strenuous exercise.
Am J Physiol 263: E64–71.
Obesity and Fat Oxidation
PLOS ONE | www.plosone.org 10 February 2014 | Volume 9 | Issue 2 | e88707
